SynthesisEuropean journal of pain (London, England)2026
Structural and Functional Neuroimaging Findings in Fibromyalgia: A Systematic Review.
Synthesis in European journal of pain (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveFibromyalgia (FM) is a nociplastic chronic pain syndrome in which neuroimaging indicates central nervous system involvement, yet findings remain inconsistent across methods. We systematically reviewed structural and functional neuroimaging studies in adults with FM to identify the most reproducible cross-modal alterations. DATABASES AND DATA TREATMENT: Following a PROSPERO-registered protocol (CRD420251234980) and PRISMA 2020, we searched PubMed, EMBASE, Web of Science and VHL/BVS for English-language studies published between 1 January 2010 and 16 October 2025. Eligible studies compared FM (any American College of Rheumatology criteria) with healthy controls and reported quantitative structural MRI, diffusion/structural connectivity or resting-state/task-based fMRI.
resultsNinety-one studies were included (24 morphometry, 8 diffusion/structural connectivity, 32 resting-state fMRI, 40 task-based fMRI). Morphometry most consistently showed reduced grey matter volume or cortical thickness in anterior cingulate, insular and prefrontal/orbitofrontal cortices, with recurrent reductions in temporal cortex, posterior cingulate, amygdala and hippocampus; thalamic increases were less frequent. Diffusion findings were sparse and bidirectional, yielding no stable white-matter alterations. Resting-state fMRI was highly heterogeneous, with contradictory default-mode, salience/insula and periaqueductal grey (PAG)-related connectivity changes. Task-based fMRI provided the clearest support for central sensitization, showing hyper-responsivity of nociceptive networks with dysregulated prefrontal engagement and weakened rostral anterior cingulate cortex (rACC)-PAG/brainstem descending modulation.
conclusionsFM shows distributed brain alterations, with the most robust signals reflecting nociceptive amplification and impaired top-down control. Harmonized longitudinal multimodal studies are needed to establish reliable biomarkers. SIGNIFICANCE STATEMENT: This systematic review shows that fibromyalgia neuroimaging findings are not best explained by a single biomarker, but by distributed alterations across pain-processing, modulatory and affective-cognitive systems. By comparing structural MRI, diffusion imaging, resting-state fMRI and task-based fMRI, the review identifies task-evoked nociceptive amplification and impaired descending modulation as the most coherent cross-study signal, while clarifying why resting-state and diffusion findings remain difficult to translate clinically.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.